Let be clear thats not what has been said. ALL POTENTIAL...

First 10 Last

Share
Profile

Follow
blackeyed

4,864 Posts.

2133

10/08/22

11:36

Post #: 63029838
Share

Originally posted by minimoke: ↑

Just so we are clear. A tthis point all we have is an A2 market announcement on wha twas said. We do not have an announcement by the FDA. And the FDA is pretty good at its daily news updates. Maybe that is simply a function of time zones.

However what is a reality is that there was a sever shortage of IF in the USA. This has been mitigated to some extent by foreign imports and internal US manufacturing is rampling up again. Along with interstate product transfers within WIC's

We can argue semantics around the words "deferred" or "rejected" but bottom line to me seems to be that A2 is no longer in the running.

Lets face it. This created a bit of excitement and no doubt day traders have done very nicely out of this over the past few months. In the absence of any other news time to just sit back, take a breath, relax and wait for the year end announcement details.

Expand

Let be clear thats not what has been said. ALL POTENTIAL APPLICANTS HAVE RECEIVED THE SAME LETTER OF DEFERRAL, so no you cannot infer A2 is no longer in the running. That is a false narrative.

A2M Price at posting: $4.71 Sentiment: Buy Disclosure: Held
3 Upvote

1 Great analysis

Reply

Top Stories

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 10 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $7.77		Change -0.035(0.45%)		Mkt cap ! $5.611B

Open	High	Low	Value	Volume
$7.87	$7.87	$7.71	$3.150M	405.5K

Buyers (Bids)

No.	Vol.	Price($)
13	5071	$7.76

Sellers (Offers)

Price($)	Vol.	No.
$7.77	37414	20

View Market Depth

No.	Vol.	Price($)
25	11616	7.750
15	9645	7.740
18	28983	7.730
10	11374	7.720
11	13510	7.710

Price($)	Vol.	No.
7.760	1662	10
7.770	41113	15
7.780	4378	8
7.790	14101	9
7.800	28659	13

Last trade - 12.23pm 27/06/2025 (20 minute delay)

A2M (ASX) Chart

Let be clear thats not what has been said. ALL POTENTIAL...

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Let be clear thats not what has been said. ALL POTENTIAL...

Top Stories

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News